United States was Eli Lilly’s largest region in fiscal 2015, bringing in $10.10B of $19.96B (51%).
| Geography | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 |
|---|---|---|---|---|---|---|
| United States | $12.31B | $12.89B | $9.13B | $10.10B | ||
| Europe | $4.26B | $4.34B | $4.51B | $3.94B | ||
| Other Foreign Countries | $3.78B | $3.82B | $3.95B | $3.88B | ||
| Japan | $2.25B | $2.06B | $2.03B | $2.03B | ||
| Total | $22.60B | $23.11B | $19.62B | $19.96B |
Eli Lilly brought in $19.96B from its four regions in fiscal 2015, the year ended December 31, 2015. That was up 1.7% from $19.62B in fiscal 2014. United States was the largest at $10.10B (50.6%), ahead of Europe at $3.94B (19.8%) and Other Foreign Countries at $3.88B (19.5%). The remaining region, Japan, brought in $2.03B.
Compared with fiscal 2014, United States grew fastest, up 10.5% to $10.10B, while Europe fell the most, down 12.5% to $3.94B. From fiscal 2012 to 2015, combined revenue from these regions fell from $22.60B to $19.96B, a compound annual decline of 4.1%. United States' share of the total fell from 54.5% to 50.6%.
Eli Lilly (LLY) reports its revenue by geography. In fiscal 2015, United States was its largest region, bringing in $10.10B (50.6% of the total), followed by Europe at $3.94B (19.8%).
United States was Eli Lilly's largest region in fiscal 2015, bringing in $10.10B, or 50.6% of the $19.96B total across its four regions.
Among Eli Lilly's regions that make up at least 2% of revenue, United States grew fastest in fiscal 2015, up 10.5% from $9.13B to $10.10B.
Every figure comes from Eli Lilly's annual financial filings, as reported. Each line keeps the name Eli Lilly gives it, and years follow its fiscal calendar.
Eli Lilly's revenue by geography goes back to fiscal 2010, with figures through fiscal 2015. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.